3-Bromopyruvic acid (3BP) is ap otential anticancer drug, the action of which on cellular metabolism is not yet entirely clear.T he presenceo fabromine atom suggests that it is also reactive towards low-energy electrons, which are produced in large quantities during tumour radiation therapy.D etailed knowledge of the interaction of 3BP with secondary electrons is aprerequisite to gain acomplete picture of the effects of 3BP in different forms of cancer therapy.H erein, dissociative electron attachment (DEA) to 3BP in the gas phase has been studied both experimentally by using ac rossed-beam setupa nd theoretically through scattering and quantum chemical calculations.T hese results are complemented by av acuum ultraviolet absorption spec-trum. The main fragmentation channel is the formation of Br À close to 0eVand within severalr esonant features at 1.9 and 3-8 eV.A tl ow electron energies, Br À formation proceeds through s*a nd p*s hape resonances,a nd at higher energies through core-excited resonances.I ti sf ound that the electron-capture cross-section is clearly increased compared with that of non-brominated pyruvic acid, but, at the same time, fragmentation reactions through DEA are significantly altereda sw ell. The 3BP transient negative ion is subject to al ower number of fragmentation reactions than those of pyruvic acid, which indicates that 3BP could indeed act by modifyingt he electron-transport chains within oxidative phosphorylation.I tc ould also act as aradio-sensitiser.